NDA 22226, held by Teva Parenteral. Pantoprazole Sodium.
As of Nov 13, 2026, NDA 22226 (Pantoprazole Sodium), held by Teva Parenteral, was not approved, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 20, 2008 | Original applicationNew formulation or manufacturer · Standard review | Tentative approval |
| Product | Active ingredient | Marketing |
|---|---|---|
| Pantoprazole Sodium40MG · injectable; injection | Pantoprazole Sodium | None (tentative approval) |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
